NO964760D0 - MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis - Google Patents

MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis

Info

Publication number
NO964760D0
NO964760D0 NO964760A NO964760A NO964760D0 NO 964760 D0 NO964760 D0 NO 964760D0 NO 964760 A NO964760 A NO 964760A NO 964760 A NO964760 A NO 964760A NO 964760 D0 NO964760 D0 NO 964760D0
Authority
NO
Norway
Prior art keywords
msrv
pathogenic
infectious
virus
rheumatoid arthritis
Prior art date
Application number
NO964760A
Other languages
Norwegian (no)
Other versions
NO964760L (en
Inventor
Herve Perron
Bernard Mandrand
Francois Mallet
Frederic Bedin
Frederic Beseme
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Publication of NO964760D0 publication Critical patent/NO964760D0/en
Publication of NO964760L publication Critical patent/NO964760L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO964760A 1995-03-09 1996-11-08 MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis NO964760L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9502960A FR2731356B1 (en) 1995-03-09 1995-03-09 MSRV-1 VIRUS AND PATHOGENIC AND / OR INFECTING MSRV-2 AGENT ASSOCIATED WITH RHUMATOID POLYARTHRITIS
PCT/FR1996/000360 WO1996028552A1 (en) 1995-03-09 1996-03-07 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2

Publications (2)

Publication Number Publication Date
NO964760D0 true NO964760D0 (en) 1996-11-08
NO964760L NO964760L (en) 1996-11-08

Family

ID=9477022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964760A NO964760L (en) 1995-03-09 1996-11-08 MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis

Country Status (11)

Country Link
EP (1) EP0731168A1 (en)
JP (1) JPH08322579A (en)
AU (1) AU5007396A (en)
BR (1) BR9605926A (en)
CA (1) CA2171242A1 (en)
CZ (1) CZ328796A3 (en)
FR (1) FR2731356B1 (en)
NO (1) NO964760L (en)
NZ (1) NZ303694A (en)
PL (1) PL317200A1 (en)
WO (1) WO1996028552A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737500B1 (en) * 1995-08-03 1997-08-29 Bio Merieux VIRAL MATERIAL AND NUCLEOTIDE FRAGMENTS ASSOCIATED WITH MULTIPLE SCLEROSIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS
US6582703B2 (en) * 1996-11-26 2003-06-24 Bio Merieux Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting
DE69836484T2 (en) * 1997-07-07 2007-09-13 Bio Merieux Endogenous retroviral genomic cliniin element associated with autoimmune disease and / or perturbation, use as a marker
FR2765588A1 (en) 1997-07-07 1999-01-08 Bio Merieux RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS ESPECIALLY ASSOCIATED WITH MULTIPLE SCLEROSIS AND / OR RHUMATOID POLYARTHRITIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS
FR2788784A1 (en) 1999-01-21 2000-07-28 Bio Merieux New nucleic acid from human endogenous retrovirus, useful e.g. for diagnosis of autoimmune disease and complications of pregnancy, contains at least part of the gag gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689520B1 (en) * 1992-04-03 1996-07-19 Bio Merieux METHOD AND CULTURE MEDIUM FOR OBTAINING CELLS INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS.
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
AU704440B2 (en) * 1994-02-04 1999-04-22 Bio Merieux MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same

Also Published As

Publication number Publication date
JPH08322579A (en) 1996-12-10
EP0731168A1 (en) 1996-09-11
NO964760L (en) 1996-11-08
FR2731356B1 (en) 1997-04-30
PL317200A1 (en) 1997-03-17
CZ328796A3 (en) 1997-03-12
NZ303694A (en) 1997-11-24
CA2171242A1 (en) 1996-09-10
FR2731356A1 (en) 1996-09-13
BR9605926A (en) 1997-09-02
AU5007396A (en) 1996-10-02
WO1996028552A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
DE69421971D1 (en) Recipients and recipient procedures
DE69412367D1 (en) Sheet buffer system
FI944310A0 (en) Heteroarylamino- and heteroaryl-sulfonamido-substituted 3-benzylaminomethyl-piperidines and the like
DE69425782D1 (en) Hyterosalpingography and selective salpingography
DE69404155D1 (en) FIRE-RESISTANT AND RETRORE-REFLECTIVE STRUCTURE
DE69327326D1 (en) REPLACEMENT AND DETECTION PROCESS
NO954635L (en) Ribozyme therapy for HIV infections and AIDS
DE69211715D1 (en) DAMPING AND SUSPENSION SUSPENSION SYSTEM
ID23485A (en) FRAMEWORK AND SUBLANTAI SHEET FRAMEWORK
FI944624A (en) 4-Arylaminobenzopyran and the like
FI953461A0 (en) Soft Decision Estimation Unit and Maximum Probability Sequence Estimation Unit
NO954880D0 (en) Cytidine deaminase
NO306299B1 (en) Oxathiolanes and pharmaceuticals with the same antiviral action
DE69404143D1 (en) DETECTION SYSTEM AND DETECTION METHOD
NO964760D0 (en) MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis
CY2008005I2 (en) MUMPS VACCINE CONTAINING THE JERYL-LYNN STRAIN VIRUS
DK0687728T3 (en) Reovirus strain 2177 and vaccine containing the same
NO951277D0 (en) High molecular weight desulfatohirudin
BR9501119A (en) Inverter system and sheet stacker
BR9407988A (en) Vaccine design and production
DE69122912D1 (en) Suspension polymerization process and toner compositions
BR9104969A (en) BOTTLING AND PERFECTING EQUIPMENT
EP0603615A3 (en) Process of purification and enrichment of the Rubella Virus.
FI952222A0 (en) Foerfarande and anordingar Foer att laengsriktat omsluta en metal-ledare med en eller flera isolerfilmer
FI932020A0 (en) BAOT FOERSEDD MED FJAEDRANDE UPPHAENGDA SKIDOR ELLER PONTONER